Curzion Pharmaceuticals Acquired by Horizon Therapeutics

Eric Linsley offered his perspective on personalized medicine’s development during a symposium for PMC’s recent report, The Case for Personalized Medicine. Linsley joined Jennie Hunter-Cevera, Ph.D., Executive Vice President, RTI International; Jonathan Roy, Senior Director and Head of Commercial Diagnostics for GlaxoSmithKline; Amy Abernethy, M.D., Director, Cancer Care Research Program at Duke University and David King, CEO of the Laboratory Corporation of America.

The Personalized Medicine Coalition latest newsletter summarizes these perspectives.